The University of Tokyo · Graduate School of Medical Sciences / Faculty of Medicine · 教授

Research keywordstype 2 diabetes pharmacotherapy・adiponectin・PAI-1・5-HT2A receptor signaling・acetate-induced AMPK activation・glycemic control・diabetes stigma

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
• Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men.
• Digital Therapeutics and Type 2 Diabetes: A Review
• Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database.

• アディポネクチンの2型糖尿病・高脂血症・動脈硬化症における病態生理学的意義の解明
• 糖代謝調節・動脈硬化症における血管内皮インスリン受容体基質-2の役割の解明
• アディポネクチン受容体の生理・病態生理的意義の解明と生活習慣病治療の分子標的同定
• アディポネクチン/アディポネクチン受容体の増加・活性化剤の開発と成分同定

• Official profile